DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Citigroup Maintains Neutral on Quest Diagnostics, Raises Price Target to $113

Citigroup maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $110 to $113.

Benzinga · 02/03/2020 13:34

Citigroup maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $110 to $113.